Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP724931.RAwZYgiEf2L6zE-BR65Vv9XXeP79e-CUw825vsPUaBe8k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP724931.RAwZYgiEf2L6zE-BR65Vv9XXeP79e-CUw825vsPUaBe8k130_assertion type Assertion NP724931.RAwZYgiEf2L6zE-BR65Vv9XXeP79e-CUw825vsPUaBe8k130_head.
- NP724931.RAwZYgiEf2L6zE-BR65Vv9XXeP79e-CUw825vsPUaBe8k130_assertion wasGeneratedBy ECO_0000203 NP724931.RAwZYgiEf2L6zE-BR65Vv9XXeP79e-CUw825vsPUaBe8k130_provenance.
- NP724931.RAwZYgiEf2L6zE-BR65Vv9XXeP79e-CUw825vsPUaBe8k130_assertion wasDerivedFrom befree-2016 NP724931.RAwZYgiEf2L6zE-BR65Vv9XXeP79e-CUw825vsPUaBe8k130_provenance.
- NP724931.RAwZYgiEf2L6zE-BR65Vv9XXeP79e-CUw825vsPUaBe8k130_assertion SIO_000772 19274700 NP724931.RAwZYgiEf2L6zE-BR65Vv9XXeP79e-CUw825vsPUaBe8k130_provenance.
- NP724931.RAwZYgiEf2L6zE-BR65Vv9XXeP79e-CUw825vsPUaBe8k130_assertion evidence source_evidence_literature NP724931.RAwZYgiEf2L6zE-BR65Vv9XXeP79e-CUw825vsPUaBe8k130_provenance.
- NP724931.RAwZYgiEf2L6zE-BR65Vv9XXeP79e-CUw825vsPUaBe8k130_assertion description "[The characterization of the estrogen receptor ligand-binding domain co-crystallized with agonists or antagonists provided a molecular basis to gain an insight into the regulation of estrogen receptor and, thereby, to describe the mechanism of the hormone therapy in treating breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP724931.RAwZYgiEf2L6zE-BR65Vv9XXeP79e-CUw825vsPUaBe8k130_provenance.